Used as a chiral intermediate in the synthesis of biologically active compounds, particularly in the development of pharmaceuticals where stereochemistry plays a critical role. Its trifluoroacetamido group enhances metabolic stability and influences binding affinity, making it valuable in optimizing drug candidates. Commonly employed in asymmetric synthesis to introduce chirality in peptidomimetics and enzyme inhibitors. The cyclohexyl moiety contributes to lipophilicity, improving membrane permeability in drug design.